Malin Life Sciences Holdings Ltd - 06 Dec 2021 Form 4 Insider Report for Poseida Therapeutics, Inc.

Signature
/s/ Pat Jennings, Chief Financial Officer
Issuer symbol
N/A
Transactions as of
06 Dec 2021
Net transactions value
+$12,613
Form type
4
Filing time
07 Dec 2021, 05:03:52 UTC
Previous filing
02 Dec 2021
Next filing
10 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX COMMON STOCK Purchase $12,613 +1,828 +0.02% $6.90 9,685,673 06 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.